Key statistics
As of last trade Penumbra Inc (PEN:NYQ) traded at 245.98, -11.31% below its 52-week high of 277.34, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 247.29 |
---|---|
High | 249.86 |
Low | 245.98 |
Bid | 245.77 |
Offer | 246.81 |
Previous close | 244.84 |
Average volume | 304.22k |
---|---|
Shares outstanding | 38.38m |
Free float | 36.89m |
P/E (TTM) | 284.62 |
Market cap | 9.40bn USD |
EPS (TTM) | 0.8602 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 16:44 GMT.
More ▼
- Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
- New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
- Penumbra, Inc. Reports Third Quarter 2024 Financial Results
- Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
- Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism
- Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
- Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
- Penumbra, Inc. to Present at the Baird Global Healthcare Conference
More ▼